Key Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
Key Pharmacy and Compounding Center is recalling 5-MTHF 10mL multiple-dose vials due to a lack of assurance of sterility. The product was distributed in the U.S., Australia, and Canada.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of assurance of sterility in a compounded drug, which poses a risk of harm without reported illnesses, fitting the High severity criteria.
Plain-English summary
Key Pharmacy and Compounding Center is recalling 5-MTHF 10ML MDV (CALIF) 5MG/ML INJ, a prescription-only sterile compounded drug. The recall involves 10mL glass multiple-dose vials containing 5mg/mL of 5-MTHF. The firm is recalling these products within their expiry dates due to a lack of assurance of sterility.
The affected lots include t11-17-2016@86, t12-22-2016@103, t01-09-2017@111, t01-11-2017@118, t01-18-2017@89, and t01-20-2017@83. The source text does not specify the total number of vials recalled, though the structured data indicates a quantity of 6 vials. The product was distributed nationwide in the U.S.A., as well as in Australia and Canada.
Consumers and healthcare providers should check their inventory for the specific lot numbers and expiration dates listed above. If the product is found, it should be discontinued and returned to the pharmacy or manufacturer for disposal. The source text does not report any illnesses or injuries associated with this recall.
The recalled product
- Product
- 5-MTHF 10ML MDV (CALIF) 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10mLGlass/Multiple Dose vial, Prepared by Key Compounding Pharmacy
- Manufacturer
- Key Pharmacy and Compounding Center
- Category
- Drug — Compounded Sterile Drug
- Affected units
- 6
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lot # t11-17-2016@86
- Exp 5/17/2017
- t12-22-2016@103
- Exp 7/4/2017
- t01-09-2017@111
- Exp 7/9/2017
- t01-11-2017@118
- Exp 7/11/2017
- t01-18-2017@89
- Exp 7/18/2017
- t01-20-2017@83
- Exp 7/23/2017.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Key Pharmacy and Compounding Center under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Key Pharmacy and Compounding Center
See all →- SevereKey Pharmacy Recalls Pyridoxal-5-Phosphate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Sterile Compounded Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighKey Pharmacy Recalls Vitamin D3 Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls 5-MTHF Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- SevereKey Pharmacy Recalls Folic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29